Myriad Genetics (MYGN) Q1 2026 Earnings

23FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.05
-0.02
0.02
0.05

Details

Expected EPS
-0.014927
Actual EPS
0.04
Surprise EPS
0.05
Surprise Percent
+367.97%

Description

Myriad Genetics (MYGN) has reported earnings of 0.04 per share for Q1 2026.

0 Comments

Share your thoughts